Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - COVID-19 Prevention
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Renal Transplant Maintenance
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Wet AMD
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - COPD
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Psoriatic Arthritis
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Urology
  - BACK
  - Urology
  - Uncomplicated Urinary Tract Infections
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

experspadmin

Minimal Residual Disease and Plasma Biomarkers in Chronic Lymphocytic Leukemia: Today and Tomorrow

Minimal Residual Disease and Plasma Biomarkers in Chronic Lymphocytic Leukemia: Today and Tomorrow

clinical topic updates
By William G. Wierda, MD, PhD

Fixed-Duration Combination Therapy vs Indefinite Therapy for Chronic Lymphocytic Leukemia

Fixed-Duration Combination Therapy vs Indefinite Therapy for Chronic Lymphocytic Leukemia

clinical topic updates

Novel Treatments for Patients With Advanced Gastrointestinal Stromal Tumors

Novel Treatments for Patients With Advanced Gastrointestinal Stromal Tumors

expert roundtables
By Arun Singh, MD; Jonathan C. Trent, MD, PhD; Michael C. Heinrich, MD

Pathologic and Molecular Risk Stratification in Patients With Gastrointestinal Stromal Tumors

Pathologic and Molecular Risk Stratification in Patients With Gastrointestinal Stromal Tumors

patient care perspectives
By Michael C. Heinrich, MD

Expert Perspectives in Systemic Lupus Erythematosus to Cover Key Topics in Systemic Lupus Erythematosus Treatment

Expert Perspectives in Systemic Lupus Erythematosus to Cover Key Topics in Systemic Lupus Erythematosus Treatment

expert perspectives
By Bevra H. Hahn, MD; George C. Tsokos, MD; Joan T. Merrill, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?